Dang Amit, Kaur Kirandeep
Founder and CEO, MarksMan Healthcare Solutions, Kopar Khairane, Navi Mumbai, Maharashtra, India.
Department of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.
Perspect Clin Res. 2016 Jan-Mar;7(1):9-14. doi: 10.4103/2229-3485.173780.
One of the important components of patient-centered healthcare is comparative effectiveness research (CER), which aims at generating evidence from the real-life setting. The primary purpose of CER is to provide comparative information to the healthcare providers, patients, and policy makers about the standard of care available. This involves research on clinical questions unanswered by the explanatory trials during the regulatory approval process. Main methods of CER involve randomized controlled trials and observational methods. The limitations of these two methods have been overcome with the help of new statistical methods. After the evidence generation, it is equally important to communicate the results to all the interested organizations. CER is beginning to have its impact in the clinical practice as its results become part of the clinical practice guidelines. CER will have far-reaching scientific and financial impact. CER will make both the treating physician and the patient equally responsible for the treatment offered.
以患者为中心的医疗保健的重要组成部分之一是比较效果研究(CER),其旨在从现实生活环境中生成证据。CER的主要目的是向医疗保健提供者、患者和政策制定者提供有关现有护理标准的比较信息。这涉及对监管审批过程中解释性试验未回答的临床问题进行研究。CER的主要方法包括随机对照试验和观察性方法。借助新的统计方法,这两种方法的局限性已被克服。在生成证据之后,将结果传达给所有感兴趣的组织同样重要。随着CER的结果成为临床实践指南的一部分,它开始在临床实践中产生影响。CER将产生深远的科学和财务影响。CER将使治疗医生和患者对所提供的治疗同样负责。